Wanbo Company has successfully renewed and upgraded its GMP certification, reinforcing its commitment to pharmaceutical-grade manufacturing standards. The certification covers peptide synthesis, purification, and packaging processes, with enhanced quality control measures implemented across all production stages.
The company also announced that all peptide batches now undergo additional third-party testing for purity, endotoxin levels, and residual solvents. Test reports (COA) are available upon request, ensuring full transparency for clients.
"We believe quality is the foundation of trust," said the company's quality assurance manager. "The upgraded certification and expanded testing protocols demonstrate our unwavering dedication to product safety and reliability."